This opportunity is no longer accepting applications.
grant RFA-CA-25-009

Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required)

The National Cancer Institute (NCI) is offering a funding opportunity to improve the implementation of lung cancer screening for populations at high risk. This grant supports research to identify effective strategies for expanding and maintaining lung cancer screening in different clinical settings and for diverse high-risk populations. The funding follows a phased approach: the UG3 phase supp…

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to advance the science of scale-up and sustainment of lung cancer screening (LCS) for populations at high risk for lung cancer. This NOFO will support studies that will identify the most effective impl…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute

Dates

Opportunity Released: October 1, 2024
Open for Submission: October 1, 2024
Submission Deadline: December 6, 2024
Application Window Closes: December 6, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.